You might have missed it, but Amazon recently launched three new Android tablets. Here are all of the details.

In this phase 3a trial, which consisted of a 56-week treatment period and a 26-week follow-up period, we randomly assigned children (6 to <12 years of age) with obesity, in a 2:1 ratio ...

Liraglutide lowered body mass, slowed weight gain and improved health markers in kids ages 6 through 11, according to ...

The 56-week trial tested Novo Nordisk’s Saxenda, the predecessor of Wegovy, coupled with lifestyle interventions in children ages 6 to 12. It found that those given daily injections of the drug ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with ...

Liraglutide for Children 6 to <12 Years of Age with Obesity — A Randomized Trial. Image Credit: Dimmo/Shutterstock.com A recent study published in The New England Journal of Medicine and ...

Liraglutide lowered body mass, slowed weight gain and improved health markers in kids ages 6 through 11 ... for children as young as 12. "To date, children have had virtually no options for ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 ... ages 10 and older and as Saxenda to treat obesity in adults and children ages 12 ...